Allergic bronchopulmonary aspergillosis

Overview 
Theory 
Diagnosis 
Management 
Follow up 
Resources 

Tezepelumab

Tezepelumab is a monoclonal antibody that binds to human thymic stromal lymphopoietin (TSLP). There are no data on the use of tezepelumab to treat allergic bronchopulmonary aspergillosis (ABPA) as of yet, but as it targets the epithelial cytokine TSLP involved in the TH2 pathway, it has theoretical benefits for the treatment of ABPA.

Use of this content is subject to our disclaimer

Allergic bronchopulmonary aspergillosis

Emerging treatments

Tezepelumab